Cargando…

Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018–2019

BACKGROUND: Scabies is a common skin infestation caused by the Sarcoptes scabei mite. Ivermectin, one of three drugs used in mass drug administration (MDA) for lymphatic filariasis, is also effective for treating scabies. Ivermectin-based MDA was first conducted in Samoa in August 2018, with ivermec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willis, Gabriela A., Kearns, Therese, Mayfield, Helen J., Sheridan, Sarah, Thomsen, Robert, Naseri, Take, David, Michael C., Engelman, Daniel, Steer, Andrew C., Graves, Patricia M., Lau, Colleen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497159/ https://www.ncbi.nlm.nih.gov/pubmed/37607196 http://dx.doi.org/10.1371/journal.pntd.0011549

Ejemplares similares

Lymphatic filariasis epidemiology in Samoa in 2018: Geographic clustering and higher antigen prevalence in older age groups
por: Lau, Colleen L., et al.
Publicado: (2020)

A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018
por: Willis, Gabriela A., et al.
Publicado: (2020)

Evaluating Molecular Xenomonitoring as a Tool for Lymphatic Filariasis Surveillance in Samoa, 2018–2019
por: McPherson, Brady, et al.
Publicado: (2022)

Supporting elimination of lymphatic filariasis in Samoa by predicting locations of residual infection using machine learning and geostatistics
por: Mayfield, Helen J., et al.
Publicado: (2020)

Triple-Drug Treatment Is Effective for Lymphatic Filariasis Microfilaria Clearance in Samoa
por: Graves, Patricia M., et al.
Publicado: (2021)

Comparison of Immunochromatographic Test (ICT) and Filariasis Test Strip (FTS) for Detecting Lymphatic Filariasis Antigen in American Samoa, 2016
por: Sheel, Meru, et al.
Publicado: (2021)

Burden of hydrocoele assessed from medical and surgical records in a lymphatic filariasis endemic country, Samoa
por: Ah Leong-Lui, Tile A., et al.
Publicado: (2019)

Spatially Explicit Environmental Factors Associated with Lymphatic Filariasis Infection in American Samoa
por: Lemin, Morgan E., et al.
Publicado: (2022)

Demographic, socioeconomic and disease knowledge factors, but not population mobility, associated with lymphatic filariasis infection in adult workers in American Samoa in 2014
por: Graves, Patricia M., et al.
Publicado: (2020)

Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame
por: Lau, Colleen L., et al.
Publicado: (2016)

Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration
por: Lau, Colleen L., et al.
Publicado: (2017)

Seroprevalence and Spatial Epidemiology of Lymphatic Filariasis in American Samoa after Successful Mass Drug Administration
por: Lau, Colleen L., et al.
Publicado: (2014)

Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration
por: Coutts, Shaun P., et al.
Publicado: (2017)

Lymphatic filariasis in 2016 in American Samoa: Identifying clustering and hotspots using non-spatial and three spatial analytical methods
por: Wangdi, Kinley, et al.
Publicado: (2022)

Spatial predictive risk mapping of lymphatic filariasis residual hotspots in American Samoa using demographic and environmental factors
por: Cadavid Restrepo, Angela M., et al.
Publicado: (2023)

Lymphatic filariasis endgame strategies: Using GEOFIL to model mass drug administration and targeted surveillance and treatment strategies in American Samoa
por: Shaw, Callum, et al.
Publicado: (2023)

Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania
por: Martin, Diana, et al.
Publicado: (2018)

Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016
por: Sheel, Meru, et al.
Publicado: (2018)

Potential use of antibodies to provide an earlier indication of lymphatic filariasis resurgence in post–mass drug ad ministration surveillance in American Samoa
por: Cadavid Restrepo, Angela M., et al.
Publicado: (2022)

Opportunities to investigate the effects of ivermectin mass drug administration on scabies
por: Engelman, Daniel, et al.
Publicado: (2013)

Potential strategies for strengthening surveillance of lymphatic filariasis in American Samoa after mass drug administration: Reducing ‘number needed to test’ by targeting older age groups, hotspots, and household members of infected persons
por: Lau, Colleen L., et al.
Publicado: (2020)

Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa
por: Won, Kimberly Y., et al.
Publicado: (2018)

Control Strategies for Scabies
por: Engelman, Daniel, et al.
Publicado: (2018)

Molecular Xenomonitoring Using Mosquitoes to Map Lymphatic Filariasis after Mass Drug Administration in American Samoa
por: Schmaedick, Mark A., et al.
Publicado: (2014)

Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and Azithromycin
por: Marks, Michael, et al.
Publicado: (2020)

Adapting the WHO package of essential noncommunicable disease interventions, Samoa
por: Bollars, Caroline, et al.
Publicado: (2018)

Ivermectin and permethrin for treating scabies
por: Rosumeck, Stefanie, et al.
Publicado: (2018)

Application of the Filariasis CELISA Antifilarial IgG(4) Antibody Assay in Surveillance in Lymphatic Filariasis Elimination Programmes in the South Pacific
por: Joseph, Hayley, et al.
Publicado: (2011)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin
por: Wilson, Nana O., et al.
Publicado: (2016)

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis
por: Alshehri, Abdullah, et al.
Publicado: (2023)

Population pharmacokinetics of ivermectin for the treatment of scabies in Indigenous Australian children
por: Gwee, Amanda, et al.
Publicado: (2020)

The Global Programme to Eliminate Lymphatic Filariasis: History and achievements with special reference to annual single-dose treatment with diethylcarbamazine in Samoa and Fiji
por: Kimura, Eisaku
Publicado: (2011)

Leptospirosis, American Samoa
por: Lau, Colleen L., et al.
Publicado: (2012)

Scabies and impetigo in Samoa: A school-based clinical and molecular epidemiological study
por: Taiaroa, George, et al.
Publicado: (2020)

Tobacco smoking patterns in Samoa in 2010: Implications for interventions
por: Adia, Alexander C., et al.
Publicado: (2019)

Oral ivermectin treatment for an infant with crusted scabies
por: Bourkas, Adrienn N., et al.
Publicado: (2023)

The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific
por: Rainima-Qaniuci, Merelesita, et al.
Publicado: (2022)

Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial
por: Romani, Lucia, et al.
Publicado: (2019)

Impact of ivermectin administered for scabies treatment on the prevalence of head lice in Atoifi, Solomon Islands
por: Coscione, Suny, et al.
Publicado: (2018)

Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community
por: Kearns, Thérèse M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e024kibgd81mquruv36isecggk